Mark A. Wilson - 13 Dec 2023 Form 4 Insider Report for NEKTAR THERAPEUTICS (NKTR)

Role
Chief Legal Officer
Signature
Mark A. Wilson, Attorney-in-Fact
Issuer symbol
NKTR
Transactions as of
13 Dec 2023
Transactions value $
$0
Form type
4
Filing time
15 Dec 2023, 18:05:59
Previous filing
20 Nov 2023
Next filing
22 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NKTR Stock Option Award $0 +325K $0.00 325K 13 Dec 2023 Common Stock 325K $0.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option vests over three years from the date of grant, (December 13, 2023) in equal monthly installments based on continued service.